10 results
10-KT
AGTX
Agentix Corp.
18 Jul 22
Annual report (with FYE transition)
11:42am
antibody with targets the peripheral CB1 receptor. Inversago Pharma is developing a peripherally-restricted CB1 inverse agonist as a possible
S-8 POS
EX-99.1
AGTX
Agentix Corp.
8 Jan 21
Registration of securities for employees (post-effective amendment)
3:46pm
of an Award (including, but not limited to, the exercise price, any applicable Performance Measures or performance targets established with respect to any … , without limitation, vesting upon the satisfaction of one or more performance targets based on one or more Performance Measures. A Participant may
S-8
EX-99.1
AGTX
Agentix Corp.
4 Jan 21
Registration of securities for employees
4:27pm
and conditions of an Award (including, but not limited to, the exercise price, any applicable Performance Measures or performance targets established … in its sole discretion, including, without limitation, vesting upon the satisfaction of one or more performance targets based on one or more
10-K
yru5si2u4 xm
16 Dec 15
Annual report
12:00am
- Prev
- 1
- Next